Aragen Bioscience Licenses Protein Production Technology from Proteonic Biotechnology

News   Sep 10, 2015

 
Aragen Bioscience Licenses Protein Production Technology from Proteonic Biotechnology
 
 
 

RELATED ARTICLES

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

Epigenomic Analyses Could Lead to Novel Therapeutic Drug Targets for Many Diseases

News

Researchers have decoded the epigenetic landscape for rheumatoid arthritis (RA), In unveiling RA’s epigenome scientists made a surprising discovery: an overlap between the causes of RA and Huntington’s disease, a fatal and incurable genetic brain disease.

READ MORE

Kinase Enzyme Movement Could Be Key to Novel Cancer Drugs

News

Revealing all the steps required to activate an enzyme called a protein kinase may identify new ways to target cancer, according to new University of Arizona-led research.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE